Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
about
Effect of oral linezolid on the pressor response to intravenous tyramine.2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.3-Coumaranone derivatives as inhibitors of monoamine oxidase.Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disordersNovel monoamine oxidase inhibitors: a patent review (2012 - 2014).Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI.Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.Methylene blue and its analogues as antidepressant compounds.MAO inhibitors and their wider applications: a patent review.Indanones as high-potency reversible inhibitors of monoamine oxidase.The Synthesis and Evaluation of C7-Substituted α-Tetralone Derivatives as Inhibitors of Monoamine Oxidase.Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.Characterization of forced degradation products of toloxatone by LC-ESI-MS/MS.
P2860
Q35826505-29E5AA0B-7613-4BCB-A311-8EB5B5508CD2Q35867089-C4439E8A-E272-4456-A90E-3D893E02B604Q36140140-6BBB8F76-57A0-43B9-ACC1-2B3040923AADQ36387362-7E212AAF-7AB8-4966-9900-82897399A9F1Q38268523-D05AEA7E-ACFF-49C2-ACE1-C08FC4032793Q39284988-88A60BBC-AD4B-44C9-8999-ED4746146528Q43613495-2D6C22BD-A8D7-44B7-8C0F-DC06174D118CQ46327960-04CDCD0D-F87E-465D-A3A3-EA310824A032Q47658356-2FEB1B5A-98ED-42C5-9655-CC1B14AC8A88Q48087297-A0FF1994-7CE4-46CF-AA2D-104C6C04917EQ48136220-6C9763B3-F567-48A4-AE01-841DD1CB491DQ51588132-DDF526F0-3A1C-4E02-94C6-501448A8723DQ53779695-A568B720-9042-4467-B458-8DFD63E4FEE5Q55010548-4027BFEE-968F-4E3C-9172-3604AE102CC3
P2860
Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@ast
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@en
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@nl
type
label
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@ast
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@en
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@nl
prefLabel
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@ast
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@en
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@nl
P2093
P356
P1476
Pharmacokinetic and pharmacody ...... tyramine in healthy subjects.
@en
P2093
D'Estanque J
Funck-Brentano C
Provost JC
P304
P356
10.1038/CLPT.1992.159
P407
P577
1992-10-01T00:00:00Z